Ambu

Share Issue/Capital Change • Nov 21, 2014

Ambu A/S – Capital increase in connection with exercise of warrants issue

In April 2011, Ambu A/S issued 110,000 warrants each carrying a right to subscribe for one B share of nominally DKK 10. These warrants were issued to 49 employees with a vesting period of 3 years and may therefore be exercised in the trading window which was opened 13 November 2014 in connection with Ambu's annual report for the year 2013/14.

As a result, 9 employees have given instructions as to the exercise of 28,500 warrants to the agreed exercise price 160.5 in the current trading window and today, the Board of Directors of Ambu passed a resolution to carry out the capital increase relating to the warrants exercised.

By the capital increase, the share capital of Ambu will be increased by nominally DKK 285,000 from DKK 119,435,800 to DKK 119,720,800 by the issuing of 28,500 B shares. The share capital is now divided into 10,256,080 B shares of DKK 10 each and 1,716,000 A shares of DKK 10 each.

Following this exercise of warrants and in consideration of the employees having left the company, 22,500 remaining warrants relating to the 2011 program are now distributed between 8 individuals.

The new B shares are expected to be admitted to trading and official listing on NASDAQ OMX Copenhagen A/S on 26 November 2014 under the ISIN code of Ambu A/S' existing B shares (DK0010303619).

Contact Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Ambu A/S Baltorpbakken 13 DK-2750 Ballerup Tel. +45 7225 2000 CVR no.: 63 64 49 19 www.ambu.com

About Ambu

Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu bag and the legendary Blue Sensor® electrodes to our newest landmark solutions like the aScope™ – the world's first single-use flexible video scope. Our commitment to bring new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,350 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.